Literature DB >> 17010344

Jellyfish and other cnidarian envenomations cause pain by affecting TRPV1 channels.

Eva Cuypers1, Angel Yanagihara, Evert Karlsson, Jan Tytgat.   

Abstract

Cnidarian envenomations cause a burning-pain sensation of which the underlying mechanisms are unknown. Activation of TRPV1, a non-selective cation channel expressed in nociceptive neurons, leads to cell depolarisation and pain. Here, we show in vitro and in vivo evidence for desensitization-dependent TRPV1 activation in cnidarian envenomations. Cnidarian venom induced a nociceptive reactivity, comparable to capsaicin, in laboratory rats, which could be reduced by the selective TRPV1 antagonist, BCTC. These findings are the first to explain at least part of the symptomology of cnidarian envenomations and provide insights into the design of more effective treatments for this global public health problem.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17010344      PMCID: PMC1800888          DOI: 10.1016/j.febslet.2006.09.030

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  21 in total

1.  Pharmacological and biochemical properties of a toxin containing material from the jellyfish, Cyanea capillata.

Authors:  M J Walker
Journal:  Toxicon       Date:  1977       Impact factor: 3.033

2.  Subunit stoichiometry of a mammalian K+ channel determined by construction of multimeric cDNAs.

Authors:  E R Liman; J Tytgat; P Hess
Journal:  Neuron       Date:  1992-11       Impact factor: 17.173

3.  The capsaicin receptor: a heat-activated ion channel in the pain pathway.

Authors:  M J Caterina; M A Schumacher; M Tominaga; T A Rosen; J D Levine; D Julius
Journal:  Nature       Date:  1997-10-23       Impact factor: 49.962

Review 4.  Nociception and TRP Channels.

Authors:  Mitsuko Numazaki; Makoto Tominaga
Journal:  Curr Drug Targets CNS Neurol Disord       Date:  2004-12

Review 5.  Organophosphates/nerve agent poisoning: mechanism of action, diagnosis, prophylaxis, and treatment.

Authors:  Jirí Bajgar
Journal:  Adv Clin Chem       Date:  2004       Impact factor: 5.394

6.  TRP channels and thermosensation.

Authors:  Ardem Patapoutian
Journal:  Chem Senses       Date:  2005-01       Impact factor: 3.160

7.  Identification and biological evaluation of 4-(3-trifluoromethylpyridin-2-yl)piperazine-1-carboxylic acid (5-trifluoromethylpyridin-2-yl)amide, a high affinity TRPV1 (VR1) vanilloid receptor antagonist.

Authors:  Devin M Swanson; Adrienne E Dubin; Chandra Shah; Nadia Nasser; Leon Chang; Scott L Dax; Michele Jetter; J Guy Breitenbucher; Changlu Liu; Curt Mazur; Brian Lord; Lisa Gonzales; Kenway Hoey; Michele Rizzolio; Michael Bogenstaetter; Ellen E Codd; Doo H Lee; Sui-Po Zhang; Sandra R Chaplan; Nicholas I Carruthers
Journal:  J Med Chem       Date:  2005-03-24       Impact factor: 7.446

8.  Scorpion envenoming in two regions of Colombia: clinical, epidemiological and therapeutic aspects.

Authors:  R Otero; E Navío; F A Céspedes; M J Núñez; L Lozano; E R Moscoso; C Matallana; N B Arsuza; J García; D Fernández; J H Rodas; O J Rodríguez; J E Zuleta; J P Gómez; M Saldarriaga; J C Quintana; V Núñez; S Cárdenas; J Barona; R Valderrama; N Paz; A Díaz; O L Rodríguez; M D Martínez; R Maturana; L E Beltrán; M B Mesa; J Paniagua; E Flórez; W R Lourenço
Journal:  Trans R Soc Trop Med Hyg       Date:  2004-12       Impact factor: 2.184

Review 9.  Venomous pelagic coelenterates: chemistry, toxicology, immunology and treatment of their stings.

Authors:  J W Burnett; G J Calton
Journal:  Toxicon       Date:  1987       Impact factor: 3.033

10.  Intravenous ascorbic acid as a treatment for severe jellyfish stings.

Authors:  Selva Kumar; Jorge R Miranda-Massari; Michael J Gonzalez; Hugh D Riordan
Journal:  P R Health Sci J       Date:  2004-06       Impact factor: 0.705

View more
  25 in total

Review 1.  Receptor-targeting mechanisms of pain-causing toxins: How ow?

Authors:  Christopher J Bohlen; David Julius
Journal:  Toxicon       Date:  2012-04-14       Impact factor: 3.033

2.  TRPV1 as a key determinant in ciguatera and neurotoxic shellfish poisoning.

Authors:  Eva Cuypers; Angel Yanagihara; Jon D Rainier; Jan Tytgat
Journal:  Biochem Biophys Res Commun       Date:  2007-07-16       Impact factor: 3.575

Review 3.  Toxins that modulate ionic channels as tools for exploring insulin secretion.

Authors:  Carlos Manlio Diaz-Garcia; Carmen Sanchez-Soto; Marcia Hiriart
Journal:  Cell Mol Neurobiol       Date:  2010-11-03       Impact factor: 5.046

4.  Analgesic compound from sea anemone Heteractis crispa is the first polypeptide inhibitor of vanilloid receptor 1 (TRPV1).

Authors:  Yaroslav A Andreev; Sergey A Kozlov; Sergey G Koshelev; Ekaterina A Ivanova; Margarita M Monastyrnaya; Emma P Kozlovskaya; Eugene V Grishin
Journal:  J Biol Chem       Date:  2008-06-25       Impact factor: 5.157

5.  TRPV1-Targeted Drugs in Development for Human Pain Conditions.

Authors:  Mircea Iftinca; Manon Defaye; Christophe Altier
Journal:  Drugs       Date:  2021-01       Impact factor: 9.546

Review 6.  Targeting nociceptive transient receptor potential channels to treat chronic pain: current state of the field.

Authors:  Magdalene M Moran; Arpad Szallasi
Journal:  Br J Pharmacol       Date:  2017-11-06       Impact factor: 8.739

Review 7.  Transient receptor potentials (TRPs) and anaphylaxis.

Authors:  Peter K Smith; Bernd Nilius
Journal:  Curr Allergy Asthma Rep       Date:  2013-02       Impact factor: 4.806

Review 8.  Immunological and toxinological responses to jellyfish stings.

Authors:  James Tibballs; Angel A Yanagihara; Helen C Turner; Ken Winkel
Journal:  Inflamm Allergy Drug Targets       Date:  2011-10

9.  Desflurane induces airway contraction mainly by activating transient receptor potential A1 of sensory C-fibers.

Authors:  Jun-ichi Satoh; Michiaki Yamakage
Journal:  J Anesth       Date:  2009-11-18       Impact factor: 2.078

Review 10.  TRP channels and analgesia.

Authors:  Louis S Premkumar; Mruvil Abooj
Journal:  Life Sci       Date:  2012-08-14       Impact factor: 5.037

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.